United States (US) Companion Diagnostic Tests in Oncology Market (2025-2031) | Value, Size & Revenue, Segmentation, Trends, Companies, Industry, Share, Growth, Competitive Landscape, Analysis, Outlook, Forecast

Market Forecast By Detection Technique (DNA Detection, Others), By Biomarker (EGFR, KRAS, HER2, BRAF V600E, Others), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Liver Cancer, Melanoma, Others), By End-user (Hospitals, Specialty Clinics, Diagnostic Labs, Others) And Competitive Landscape
Product Code: ETC9963023 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) Companion Diagnostic Tests in Oncology Market Outlook
  • Market Size of United States (US) Companion Diagnostic Tests in Oncology Market, 2024
  • Forecast of United States (US) Companion Diagnostic Tests in Oncology Market, 2031
  • Historical Data and Forecast of United States (US) Companion Diagnostic Tests in Oncology Revenues & Volume for the Period 2021- 2031
  • United States (US) Companion Diagnostic Tests in Oncology Market Trend Evolution
  • United States (US) Companion Diagnostic Tests in Oncology Market Drivers and Challenges
  • United States (US) Companion Diagnostic Tests in Oncology Price Trends
  • United States (US) Companion Diagnostic Tests in Oncology Porter's Five Forces
  • United States (US) Companion Diagnostic Tests in Oncology Industry Life Cycle
  • Historical Data and Forecast of United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Detection Technique for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume By DNA Detection for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Biomarker for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume By EGFR for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume By KRAS for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume By HER2 for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume By BRAF V600E for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Cancer Type for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Breast Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Lung Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Colorectal Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Liver Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Melanoma for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume By End-user for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Specialty Clinics for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Diagnostic Labs for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Others for the Period 2021- 2031
  • United States (US) Companion Diagnostic Tests in Oncology Import Export Trade Statistics
  • Market Opportunity Assessment By Detection Technique
  • Market Opportunity Assessment By Biomarker
  • Market Opportunity Assessment By Cancer Type
  • Market Opportunity Assessment By End-user
  • United States (US) Companion Diagnostic Tests in Oncology Top Companies Market Share
  • United States (US) Companion Diagnostic Tests in Oncology Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Companion Diagnostic Tests in Oncology Company Profiles
  • United States (US) Companion Diagnostic Tests in Oncology Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United States (US) Companion Diagnostic Tests in Oncology Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Companion Diagnostic Tests in Oncology Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Companion Diagnostic Tests in Oncology Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Companion Diagnostic Tests in Oncology Market - Industry Life Cycle

3.4 United States (US) Companion Diagnostic Tests in Oncology Market - Porter's Five Forces

3.5 United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume Share, By Detection Technique, 2021 & 2031F

3.6 United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume Share, By Biomarker, 2021 & 2031F

3.7 United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F

3.8 United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume Share, By End-user, 2021 & 2031F

4 United States (US) Companion Diagnostic Tests in Oncology Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in the United States

4.2.2 Growing demand for personalized medicine and targeted therapies

4.2.3 Advancements in diagnostic technologies and biomarker identification

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for companion diagnostic tests

4.3.2 High costs associated with developing and commercializing companion diagnostic tests

4.3.3 Limited reimbursement policies for companion diagnostic tests

5 United States (US) Companion Diagnostic Tests in Oncology Market Trends

6 United States (US) Companion Diagnostic Tests in Oncology Market, By Types

6.1 United States (US) Companion Diagnostic Tests in Oncology Market, By Detection Technique

6.1.1 Overview and Analysis

6.1.2 United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Detection Technique, 2021- 2031F

6.1.3 United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By DNA Detection, 2021- 2031F

6.1.4 United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Companion Diagnostic Tests in Oncology Market, By Biomarker

6.2.1 Overview and Analysis

6.2.2 United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By EGFR, 2021- 2031F

6.2.3 United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By KRAS, 2021- 2031F

6.2.4 United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By HER2, 2021- 2031F

6.2.5 United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By BRAF V600E, 2021- 2031F

6.2.6 United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Others, 2021- 2031F

6.3 United States (US) Companion Diagnostic Tests in Oncology Market, By Cancer Type

6.3.1 Overview and Analysis

6.3.2 United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Breast Cancer, 2021- 2031F

6.3.3 United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Lung Cancer, 2021- 2031F

6.3.4 United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F

6.3.5 United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Liver Cancer, 2021- 2031F

6.3.6 United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Melanoma, 2021- 2031F

6.3.7 United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Others, 2021- 2031F

6.4 United States (US) Companion Diagnostic Tests in Oncology Market, By End-user

6.4.1 Overview and Analysis

6.4.2 United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.4.4 United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Diagnostic Labs, 2021- 2031F

6.4.5 United States (US) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) Companion Diagnostic Tests in Oncology Market Import-Export Trade Statistics

7.1 United States (US) Companion Diagnostic Tests in Oncology Market Export to Major Countries

7.2 United States (US) Companion Diagnostic Tests in Oncology Market Imports from Major Countries

8 United States (US) Companion Diagnostic Tests in Oncology Market Key Performance Indicators

8.1 Adoption rate of companion diagnostic tests in oncology

8.2 Number of FDA approvals for new companion diagnostic tests

8.3 Rate of integration of companion diagnostic tests in treatment decision-making in oncology practice

9 United States (US) Companion Diagnostic Tests in Oncology Market - Opportunity Assessment

9.1 United States (US) Companion Diagnostic Tests in Oncology Market Opportunity Assessment, By Detection Technique, 2021 & 2031F

9.2 United States (US) Companion Diagnostic Tests in Oncology Market Opportunity Assessment, By Biomarker, 2021 & 2031F

9.3 United States (US) Companion Diagnostic Tests in Oncology Market Opportunity Assessment, By Cancer Type, 2021 & 2031F

9.4 United States (US) Companion Diagnostic Tests in Oncology Market Opportunity Assessment, By End-user, 2021 & 2031F

10 United States (US) Companion Diagnostic Tests in Oncology Market - Competitive Landscape

10.1 United States (US) Companion Diagnostic Tests in Oncology Market Revenue Share, By Companies, 2024

10.2 United States (US) Companion Diagnostic Tests in Oncology Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All